Guidance for Workplan submissions

MeTA ‘s core hypothesis is that the disclosure of key medicines data - putting data into the public domain - will make the workings of the pharmaceutical sector, including the supply chain, more transparent, and that this will enhance efficiency, incentivise responsible business practice, and increase the accountability of key stakeholders – to each other and to the public.

The Guidance for Workplan Submissions provides advice and guidance to existing and prospective MeTA countries – and specifically their national Secretariats and multi-stakeholder groups or Councils – as they take steps towards establishing the practice of routine disclosure of key medicines data.